|
DENND5B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.292000E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.253230E-01 |
| Normal-vs-Stage2 |
6.160800E-01 |
| Normal-vs-Stage3 |
5.663600E-03 |
| Normal-vs-Stage4 |
3.057800E-03 |
| Stage1-vs-Stage2 |
5.537400E-01 |
| Stage1-vs-Stage3 |
9.950300E-02 |
| Stage1-vs-Stage4 |
6.689500E-02 |
| Stage2-vs-Stage3 |
7.338300E-02 |
| Stage2-vs-Stage4 |
2.906400E-02 |
| Stage3-vs-Stage4 |
4.627000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.462300E-02 |
| Normal-vs-AfricanAmerican |
5.048600E-01 |
| Normal-vs-Asian |
4.861900E-02 |
| Caucasian-vs-AfricanAmerican |
5.544400E-01 |
| Caucasian-vs-Asian |
7.439800E-01 |
| AfricanAmerican-vs-Asian |
4.045000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.592200E-02 |
| Normal-vs-Female |
3.939900E-02 |
| Male-vs-Female |
6.283800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.040000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.863800E-03 |
| Normal-vs-Age(61-80Yrs) |
1.823430E-03 |
| Normal-vs-Age(81-100Yrs) |
7.850000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.574300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.146400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.118800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.974400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.291200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.063800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.62115999999823E-05 |
| Classical-VS-Follicular |
3.358200E-01 |
| Classical-VS-Other |
2.839200E-01 |
| Classical-VS-Normal |
5.634100E-02 |
| Tall-VS-Follicular |
1.69588999999748E-05 |
| Tall-VS-Other |
1.814250E-02 |
| Tall-VS-Normal |
6.86150000039909E-07 |
| Follicular-VS-Other |
4.456400E-01 |
| Follicular-VS-Normal |
4.929200E-01 |
| Other-VS-Normal |
5.039400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.514000E-02 |
| Normal-vs-N1 |
1.158670E-03 |
| N0-vs-N1 |
8.512100E-02 |
|
|
